Mazar Andrew Paul
Insider CIK 1727393 · NONE Chief Scientific Officer, Director, 10% owner · ACTU Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2026-04-01 | 2026-04-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-09-24 | 2025-09-26 | 550,229 | $63.61 | $35.00M | 272,026 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-04-02 | 2025-04-04 | 33,334 | $35.00 | $1.17M | 822,255 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2025-04-01 | 2025-04-02 | 51,046 | — | $0 | 51,046 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2025-04-01 | 2025-04-02 | 110,346 | — | $0 | 110,346 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-03-31 | 2022-04-01 | 1,606 | — | $0 | 88,792 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-03-31 | 2022-04-01 | 471 | $2.55 | $1.2K | 22,125 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-03-31 | 2022-04-01 | 1,606 | — | $0 | 22,596 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 88,874 | — | $0 | 88,874 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 67,251 | — | $0 | 90,398 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-01-01 | 2022-01-04 | 1,937 | — | $0 | 3,874 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-01-01 | 2022-01-04 | 1,937 | — | $0 | 21,661 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-01-01 | 2022-01-04 | 671 | $3.21 | $2.2K | 20,990 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-12-31 | 2022-01-04 | 1,606 | — | $0 | 19,273 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-12-31 | 2022-01-04 | 556 | $3.21 | $1.8K | 19,724 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-12-31 | 2022-01-04 | 1,606 | — | $0 | 20,280 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-09-30 | 2021-10-01 | 1,606 | — | $0 | 20,879 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-09-30 | 2021-10-01 | 1,606 | — | $0 | 19,145 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-09-30 | 2021-10-01 | 471 | $4.87 | $2.3K | 18,674 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-06-30 | 2021-07-02 | 3,212 | — | $0 | 22,485 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-06-30 | 2021-07-02 | 3,212 | — | $0 | 18,481 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-06-30 | 2021-07-02 | 942 | $5.89 | $5.5K | 17,539 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 16,384 | $16.44 | $269.4K | 178,596 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 29,996 | $15.12 | $453.5K | 194,980 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 42,467 | $13.30 | $564.8K | 249,200 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 11,929 | $16.90 | $201.6K | 166,667 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 24,224 | $14.09 | $341.3K | 224,976 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 25,697 | — | $0 | 31,508 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 36,077 | — | $0 | 36,077 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-01-01 | 2021-01-05 | 1,937 | — | $0 | 5,811 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-01-01 | 2021-01-05 | 671 | $6.12 | $4.1K | 15,269 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-01-01 | 2021-01-05 | 1,937 | — | $0 | 15,940 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 32,193 | — | $0 | 32,193 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 7,748 | — | $0 | 7,748 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2019-12-18 | 2019-12-20 | 125,000 | $8.00 | $1.00M | 291,667 | SEC↗ |
| NONE Monopar Therapeutics | A Award deriv | 2018-08-09 | 2018-09-27 | 134,300 | — | $0 | 134,300 | SEC↗ |